The inclusion of a 9mg dose tier is noteworthy because it was not tested in Phase 2
In clinical trials in children and adolescents, these agents have been generally well tolerated, with gastrointestinal symptoms by far the most common adverse events
Nothing severe, just that queasy feeling you get when you eat something that does not agree with you
This means it goes under the skin, often in the stomach, thigh, or upper arm

Hormonal Effects of GLP-1 (Glucagon-Like Peptide-1): A Multi-Organ Metabolic Regulator GLP-1 is an incretin hormone that plays a central role in glucose homeostasis, appetite regulation, and metabolic health by acting on multiple organs: Brain Appetite & food intake Satiety Food palatability Provides neuroprotective actions Heart Supports cardiovascular function Contributes to cardiometabolic risk reduction Gastrointestinal Tract Gastric emptying GI motility Gastric acid secretion Helps control post-prandial glucose spikes Liver Glucose storage Gluconeogenesis Hepatic steatosis Improves insulin sensitivity and metabolic balance Pancreas Insulin secretion & synthesis (glucose-dependent) Glucagon release -cell survival & proliferation -cell apoptosis Muscle Insulin sensitivity Glucose uptake Adipose (Fat) Tissue Glucose uptake Lipolysis GLP-1 exerts pleiotropic benefits across metabolic organs, making it a cornerstone target in the management of type 2 diabetes, obesity, and cardiometabolic disorders
